Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma.
Onco Targets Ther
; 9: 5663-5669, 2016.
Article
in En
| MEDLINE
| ID: mdl-27713635
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Observational_studies
/
Risk_factors_studies
Language:
En
Journal:
Onco Targets Ther
Year:
2016
Document type:
Article
Country of publication:
New Zealand